Identification of JAK/STAT signalling components by genome-wide RNA interference

Area of Science:

• Molecular Biology
• Genetics
• Cell Biology

Background:

• Cellular signalling pathways are vital for development and homeostasis.
• Dysregulation of signalling pathways, including the Janus tyrosine kinase/signal transducer and activator of transcription (JAK/STAT) pathway, is linked to human cancers.
• The JAK/STAT pathway regulates critical cellular processes like proliferation and haematopoiesis.

Purpose of the Study:

• To conduct a genome-wide survey to identify genes essential for JAK/STAT pathway activity.
• To classify newly identified interacting proteins based on their functional relationship with known JAK/STAT components.
• To explore the role of identified genes and their human homologues in cancer biology.

Main Methods:

• Systematic genome-wide RNA interference (RNAi) screen in Drosophila melanogaster haemocyte-like cells.
• Analysis of 20,026 RNAi-induced phenotypes to identify interacting genes.
• Cell-based epistasis experiments to functionally categorize identified proteins.
• In vivo analysis of specific gene functions in leukaemia models.

Main Results:

• Identified 90 genes required for JAK/STAT pathway activity, including 4 known and 86 previously uncharacterized proteins.
• Discovered the tyrosine phosphatase Ptp61F and the Drosophila homologue of BRWD3 (dBRWD3).
• Demonstrated that disrupted dBRWD3 and overexpressed Ptp61F suppress leukaemia-like blood cell tumours in vivo.

Conclusions:

• This study provides a comprehensive identification of novel genes involved in JAK/STAT signalling.
• The findings offer molecular insights into the JAK/STAT pathway's relevance to human cancer.
• Human homologues of the identified pathway modifiers represent potential therapeutic targets for cancer treatment.